Robin Steigerwald

427 total citations
15 papers, 251 citations indexed

About

Robin Steigerwald is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Robin Steigerwald has authored 15 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Virology. Recurrent topics in Robin Steigerwald's work include Virus-based gene therapy research (3 papers), Viral Infections and Outbreaks Research (3 papers) and Herpesvirus Infections and Treatments (3 papers). Robin Steigerwald is often cited by papers focused on Virus-based gene therapy research (3 papers), Viral Infections and Outbreaks Research (3 papers) and Herpesvirus Infections and Treatments (3 papers). Robin Steigerwald collaborates with scholars based in Germany, Switzerland and United States. Robin Steigerwald's co-authors include R. Guckenberger, Paul Chaplin, Jürgen Hausmann, Kay Brinkmann, Marc Schweneker, Mark Suter, Ulrike Dirmeier, Lars E. French, Jennifer Sand and Michael Seyffert and has published in prestigious journals such as PLoS ONE, Journal of Virology and Journal of Hepatology.

In The Last Decade

Robin Steigerwald

15 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Steigerwald Germany 9 93 75 74 58 55 15 251
Yusuke Nakano Japan 14 176 1.9× 80 1.1× 137 1.9× 111 1.9× 191 3.5× 34 440
Iga Kucharska United States 11 169 1.8× 33 0.4× 17 0.2× 60 1.0× 53 1.0× 18 305
Efi Makdasi Israel 9 143 1.5× 90 1.2× 60 0.8× 127 2.2× 19 0.3× 27 299
Jori Symons Netherlands 10 130 1.4× 71 0.9× 62 0.8× 145 2.5× 158 2.9× 18 348
Laura Graf Germany 11 130 1.4× 150 2.0× 173 2.3× 75 1.3× 60 1.1× 19 379
Jeffrey W. Froude United States 12 100 1.1× 69 0.9× 96 1.3× 248 4.3× 9 0.2× 16 445
Tyler M. Renner Canada 11 166 1.8× 77 1.0× 74 1.0× 116 2.0× 69 1.3× 22 330
Meixi Chen China 6 140 1.5× 65 0.9× 92 1.2× 118 2.0× 248 4.5× 8 335
Katarzyna Skorupka United States 8 186 2.0× 102 1.4× 48 0.6× 78 1.3× 155 2.8× 12 339
Nasim Motamedi United States 9 88 0.9× 108 1.4× 65 0.9× 81 1.4× 60 1.1× 11 350

Countries citing papers authored by Robin Steigerwald

Since Specialization
Citations

This map shows the geographic impact of Robin Steigerwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Steigerwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Steigerwald more than expected).

Fields of papers citing papers by Robin Steigerwald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Steigerwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Steigerwald. The network helps show where Robin Steigerwald may publish in the future.

Co-authorship network of co-authors of Robin Steigerwald

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Steigerwald. A scholar is included among the top collaborators of Robin Steigerwald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Steigerwald. Robin Steigerwald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Henning, Lisa N., Kathrin Endt, Robin Steigerwald, Michael S. Anderson, & Ariane Volkmann. (2021). A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge. Frontiers in Immunology. 11. 598847–598847. 7 indexed citations
2.
Steigerwald, Robin, David A. Brake, José Barrera, et al.. (2019). Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle. Vaccine. 38(4). 769–778. 3 indexed citations
3.
Hu, Weigang, et al.. (2018). Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses. Vaccine. 36(34). 5194–5203. 20 indexed citations
4.
Schweneker, Marc, Andrea Laimbacher, Gert Zimmer, et al.. (2017). Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles. Journal of Virology. 91(11). 17 indexed citations
5.
Strittmatter, Gerhard E., Jennifer Sand, Marlies Sauter, et al.. (2015). IFN-γ Primes Keratinocytes for HSV-1–Induced Inflammasome Activation. Journal of Investigative Dermatology. 136(3). 610–620. 47 indexed citations
6.
Wennier, Sonia, Kay Brinkmann, Ulrike Dirmeier, et al.. (2013). A Novel Naturally Occurring Tandem Promoter in Modified Vaccinia Virus Ankara Drives Very Early Gene Expression and Potent Immune Responses. PLoS ONE. 8(8). e73511–e73511. 24 indexed citations
7.
Mandl, Stefanie, Ryan B. Rountree, Ulrike Dirmeier, et al.. (2011). Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells. Cancer Immunology Immunotherapy. 61(1). 19–29. 22 indexed citations
8.
Brinkmann, Kay, Marc Schweneker, Robin Steigerwald, et al.. (2010). Immediate-Early Expression of a Recombinant Antigen by Modified Vaccinia Virus Ankara Breaks the Immunodominance of Strong Vector-Specific B8R Antigen in Acute and Memory CD8 T-Cell Responses. Journal of Virology. 84(17). 8743–8752. 43 indexed citations
9.
Serwe, Matthias, János Ludwig, Brian S. Sproat, et al.. (2005). Hammerhead ribozymes with cleavage site specificity for NUH and NCH display significant anti-hepatitis C viral effect in vitro and in recombinant HepG2 and CCL13 cells. Journal of Hepatology. 44(6). 1017–1025. 13 indexed citations
10.
11.
Steigerwald, Robin, et al.. (1997). Hydration Scanning Tunneling Microscopy of DNA and a Bacterial Surface Protein. Journal of Structural Biology. 119(2). 212–221. 24 indexed citations
12.
Fabry, Stefan, et al.. (1995). Structure-function analysis of small G proteins from Volvox and Chlamydomonas by complementation of Saccharomyces cerevisiae YPT/SEC mutations. Molecular and General Genetics MGG. 247(3). 265–274. 16 indexed citations
13.
Langer, Róbert, Randy A. Albrecht, Sebastian Krug, et al.. (1994). Charakterisierung der 24-Stunden-Überlebensrate und Lebensdauer von mittels Hydroxyethylstärke kryokonservierten Erythrozyten nach autologer Transfusion im Hund. Transfusion Medicine and Hemotherapy. 21(6). 393–400. 2 indexed citations
14.
Langer, Róbert, et al.. (1994). [Characterization of 24-hour survival rate and duration of survival of hydroxyethyl starch cryopreserved erythrocytes after autologous transfusion in the dog].. PubMed. 21(6). 393–400. 3 indexed citations
15.
Sputtek, Andreas, Róbert Langer, Holger Schmid, et al.. (1992). [Cryopreservation of erythrocytes with hydroxyethyl starch. In vitro results leading to an autologous retransfusion model in the dog].. PubMed. 30. 292–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yusuke Nakano Breakdown of academic impact, for papers by Iga Kucharska Breakdown of academic impact, for papers by Efi Makdasi Breakdown of academic impact, for papers by Jori Symons Breakdown of academic impact, for papers by Laura Graf Breakdown of academic impact, for papers by Jeffrey W. Froude Breakdown of academic impact, for papers by Tyler M. Renner Breakdown of academic impact, for papers by Meixi Chen Breakdown of academic impact, for papers by Katarzyna Skorupka Breakdown of academic impact, for papers by Nasim Motamedi
Rankless by CCL
2026